›› 2001, Vol. 22 ›› Issue (1): 18-18.

• 论文 • 上一篇    下一篇

原发性肝癌手术治疗与肝动脉化疗栓塞疗效比较的Meta分析

何杰;刘树贤;刘殿武;杨俊英;徐宝生   

  1. 河北医科大学公共卫生学院流行病学教研室%公共卫生学院卫生统计学教研室%河北医科大学第二医院放射科
  • 发布日期:2001-01-25

Xue Xiaoying;Duan Huijun;Liu Yuanyun;LI Yingmin

He Jie;Liu Shuxian;YANG Junying;Xu Baosheng;LIU Dianwu   

  • Published:2001-01-25

摘要: 目的 采用Meta分析法,对国内、外有关原发性肝癌(hepatocellular carcinoma,HCC)的手术治疗与肝动脉化疗拴塞(transcatheter arteral chemoembolization,TAC)疗效比较的单项研究进行综合评价和定量分析。方法 Meta分析步骤包括收集相关文献、确定纳入和排除Meta分析文献标准、相关文献的质量评定、选择统计学处理方法进行资料综合。结果 HCC手术与TAE疗效对比研究的1年、3年生存率合并率差95 %可信区间分别为-0.08941~0.1177和-0.1380~0.0672,均包括“0”。结论 HCC手术与TAE的长期生存率无统计学差异(P>0.05)。

关键词: 肝肿瘤/放射治疗学, 栓塞, 治疗性/方法, 肝动脉/放射疗法, 综合分析

Abstract: Objective Meta-analysis method was used to analyze survival rates hepatocellular carcinoma(HCC)of patients treated with operation and transcatheter arterial chemoembolization(TAC) reported in different periodicals to evaluate quantitativelly the two treatment procedures.Methods The Meta-analysis was done as follows: collection of relative literatures,literatures selection according to our criterion, abstraction of analysis items from the selected reports, and selection of statistical methods.Results The results showed that the 95 % confidence interval of integrated RD of survival rated for 1 or 3 years on the treatment effect between operation and TAC are -0.0841~0.1177 and -0.1380~0.0672 respectively,all of which included zero.Conclusion There was no difference in the survival rates between HCC patients treated with operation and TAC.

中图分类号: